Rekombinanter Kollagenfüllstoff, Herstellungsverfahren dafür und Verwendung davon

EP4803110 9. September 2026

Anmelder: WitKang Zhiyuan Medical Devices (Xi'an) Co., Ltd. 🇨🇳

Details

Veröffentlichungs-Nr.
EP4803110
Anmeldetag
25. September 2025
Veröffentlichung
9. September 2026
Rechtsraum
EP
Offizieller Volltext

Abstract

The present disclosure provides a recombinant collagen filler, a preparation therefor, and the use thereof. The components of the recombinant collagen filler comprise a recombinant collagen gel and coral hydroxyapatite particles. The mass ratio of the recombinant collagen gel to the coral hydroxyapatite particles is (2.1-11) : 1. The filler further optionally comprises a first diluent. The content of the first diluent is 32.5-45.5% based on 100% of the total mass of the recombinant collagen filler. The coral hydroxyapatite particles are uniformly distributed in the recombinant collagen gel. The recombinant collagen gel is formulated from recombinant collagen microspheres and a second diluent. The filler of the present disclosure has a low cost and a high performance, the injection process thereof is fast and convenient, the action thereof is long-lasting, without a need for multiple injections, and the wrinkle removal effect thereof is long-acting and durable.

Anmelder

Firma
WitKang Zhiyuan Medical Devices (Xi'an) Co., Ltd.
Land
🇨🇳 China

Vertreten von

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen